87932-07-8

Basic information

• Product Name: 1,3-Benzenedicarboxamide, 5-(acetylamino)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo -
• CAS NO: 87932-07-8
• Molecular Formula: C16H20I3N3O7
• Molecular Weight: 747.064
• Mol File: 87932-07-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1,3-Benzenedicarboxamide, 5-(acetylamino)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo -(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Benzenedicarboxamide, 5-(acetylamino)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo -(87932-07-8)
• EPA Substance Registry System: 1,3-Benzenedicarboxamide, 5-(acetylamino)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo -(87932-07-8)

Safety Data

• Hazardous Substances Data: 87932-07-8(Hazardous Substances Data)

Usage

General Description

1,3-Benzenedicarboxamide, 5-(acetylamino)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo is a complex chemical compound that consists of a benzene ring with two carboxamide groups attached, and a triiodo-substituted acetylamino group. The chemical also contains two hydroxyethyl groups and a hydroxymethyl group. 1,3-Benzenedicarboxamide, 5-(acetylamino)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo - is used as a contrast agent in medical imaging, particularly in radiographic studies and computed tomography scans, to enhance the visibility of blood vessels and tissues. It is an important tool in diagnosing a range of medical conditions, including cardiovascular disease, cancer, and organ abnormalities. Additionally, its complex structure and unique properties make it an interesting subject for further research and development in the field of medical imaging and diagnostic techniques.

Upstream product

• 60166-98-5 S-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-amino-2,4,6-triiodo-1,3-benzenedicarboxamide 

Downstream Products

• 92339-12-3 1,4-Bis(acetylamino)-N,N'-bis[3,5-bis(1,3-dihydroxy-2-propylaminocarbonyl)-2,4,6-triiodophenyl]-2,3-dihydroxybutane 

Relevant articles and documents

X-ray contrast agents

Compounds of the general formula: STR1 (where R is a group --CH(CH2 OH)2 or --CH2 CH(OH)CH2 OH and A is a group --CH2 CH(OH)CH2 -- or --CH2 CH(OH)CH(OH)CH2 --) possess a package of favourable parameters which render them of particular use not only in all forms of intravascular visualisation but also in myelography. The compounds are prepared by reaction of an appropriate 5-acetylamino-N,N'-bis(hydroxypropyl)-2,4,6-triiodoisophthalamide with an agent effective to introduce the appropriate hydroxyalkylene group such as for example epichlorohydrin or 1,4-dichloro-2,3-dihydroxybutane.